Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Glioma 1 Glioblastoma 1

Interventions

Temozolomide 11 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiation 3 Blood Specimen Collection 3 Bevacizumab 3 tislelizumab 2 pembrolizumab 2 cemiplimab 2 Surgical Procedures, Operative 2 mirdametinib 1 gallium maltolate 1 fluzoparib 1 florbetapir 1 elemene 1 X-Rays 1 Vortioxetine 1 Transurethral Resection of Bladder 1 Spironolactone 1 Spinal Puncture 1 Sitagliptin Phosphate 1 Sampling Studies 1 Receptors, Interleukin-8B 1 Radiotherapy, Intensity-Modulated 1 Psychosocial Intervention 1 Platinum 1 Photons 1 Photochemotherapy 1 Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Glioblastoma × mirdametinib × Clear all

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡